Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06589102

Enrollment

491

Registered

2024-09-19

Start date

2022-12-28

Completion date

2023-03-30

Last updated

2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, Pancreatic Cancer, Pancreatic Cyst

Keywords

Pancreatic surgery

Brief summary

The goal of this observational study is to investigate the role of lactate elevation. The main aims are: * Determine the frequency of lactate elevation following pancreatic surgery and its relationship to postoperative complications * Investigate what patient and surgical related factors that are associated with postoperative lactate elevation This is a retrospective study based on existing medical data and will not affect the medical care of the studied patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Inclusion criteria

* Patients undergoing pancreatic surgery 2016-2018

Exclusion criteria

* Patients unable to undergo scheduled surgery * Missing data in the postoperative period

Design outcomes

Primary

Measure	Time frame	Description
Length of hospital stay	All patients are followed until they leave the hospital, but a maximum of six months	hospital stay following surgery

Secondary

Measure	Time frame	Description
General postoperative complications	All patients are followed until they leave the hospital, but a maximum of six months	Defined as Clavien-Dindo grade III-V
ICU care	All patients are followed until they leave the hospital, but a maximum of six months	Organ failure requiring ICU care
Surgery specific complications	90 days	Pancreatic fistula, bile leakage, delayed gastric emptying

Countries

Sweden

Outcome results